UK markets close in 1 hour 24 minutes
  • FTSE 100

    7,045.47
    +12.62 (+0.18%)
     
  • FTSE 250

    22,336.34
    +122.20 (+0.55%)
     
  • AIM

    1,237.83
    +3.74 (+0.30%)
     
  • GBP/EUR

    1.1620
    -0.0009 (-0.08%)
     
  • GBP/USD

    1.4186
    +0.0049 (+0.34%)
     
  • BTC-GBP

    30,378.67
    -1,337.86 (-4.22%)
     
  • CMC Crypto 200

    1,198.08
    -55.06 (-4.39%)
     
  • S&P 500

    4,154.70
    -8.59 (-0.21%)
     
  • DOW

    34,229.45
    -98.34 (-0.29%)
     
  • CRUDE OIL

    65.97
    -0.30 (-0.45%)
     
  • GOLD FUTURES

    1,866.90
    -0.70 (-0.04%)
     
  • NIKKEI 225

    28,406.84
    +582.01 (+2.09%)
     
  • HANG SENG

    28,593.81
    +399.72 (+1.42%)
     
  • DAX

    15,371.23
    -25.39 (-0.16%)
     
  • CAC 40

    6,357.65
    -9.70 (-0.15%)
     

Global Virtual Clinical Trials Market (2020 to 2026) - by Study Type, Indication and Region - ResearchAndMarkets.com

·4-min read

The "Global Virtual Clinical Trials Market By Study Type, By Indication, By Region, Industry Analysis and Forecast, 2020 - 2026" report has been added to ResearchAndMarkets.com's offering.

The Global Virtual Clinical Trials Market size is expected to reach $10 billion by 2026, rising at a market growth of 6.5% CAGR during the forecast period.

Virtual Clinical Trials (VCTs) are also known as remote or decentralized trails, are a comparatively new but still underused technique of carrying out clinical research taking complete benefit of technologies like apps, online social interaction platforms, and electronic monitoring tools. The market is significantly driven by growth in R&D activities, the growing digitization in healthcare, and the adoption of telehealth. Moreover, advances in technology, collaborations between clinical research companies, biotechnology companies, and pharmaceutical and support initiatives from governments are expected to boost the market.

Virtual clinical trials (VCT) abolish limitations presented by conventional clinical trials such as time-taking procedures and delay in recruitment of patients that has pushed the demand for the virtual clinical trial market. Additionally, advances in technology in healthcare infrastructure and partnerships between pharmaceutical, biotechnology, and clinical research companies are expected to propel the virtual clinical trials market development in the coming years.

The rise in costs, combined with a higher rate of trail failures and an expansion in patient-centric trials, has resulted in a rise in demand to adopt technology in clinical trials. In fact, virtual clinical trials are expected to rise from high revenue to the highest revenue in the upcoming years. Still despite this development, for the majority of patients, getting clinical trials is still a difficult process, with enrollment and engagement presenting new challenges.

Companies Profiled

  • IQVIA Holdings, Inc.

  • ICON PLC

  • Laboratory Corporation of America Holdings (Covance, Inc.)

  • Dassault Systemes SE (Medidata Solutions, Inc.)

  • Oracle Corporation

  • Parexel International Corporation (Pamplona Capital Management)

  • PRA Health Sciences, Inc. (KKR & Co., Inc.)

  • Medpace Holdings, Inc.

  • Medable, Inc.

  • Clinical Ink, Inc. (G.I. Partners)

Unique Offerings

  • Exhaustive coverage

  • Highest number of market tables and figures

  • Subscription based model available

  • Guaranteed best price

  • Assured post sales research support with 10% customization free

Key Topics Covered:

Chapter 1. Market Scope & Methodology

1.1 Market Definition

1.2 Objectives

1.3 Market Scope

1.4 Segmentation

1.4.1 Global Virtual Clinical Trials Market, by Study Type

1.4.2 Global Virtual Clinical Trials Market, by Indication

1.4.3 Global Virtual Clinical Trials Market, by Geography

1.5 Methodology for the research

Chapter 2. Market Overview

2.1 Introduction

2.1.1 Overview

2.1.2 Market Composition

2.2 Key Factors Impacting the Market

2.2.1 Market Drivers

2.2.2 Market Restraints

Chapter 3. Competition Analysis - Global

3.1 Cardinal Matrix

3.2 Recent Industry Wide Strategic Developments

3.2.1 Partnerships, Collaborations and Agreements

3.2.2 Product Launches and Product Expansions

3.2.3 Geographical Expansions

3.2.4 Acquisition and Mergers

3.3 Top Winning Strategies

3.3.1 Key Leading Strategies: Percentage Distribution (2016-2020)

3.3.2 Key Strategic Move: (Partnerships, Collaborations, and Agreements : 2017, Oct - 2020, Nov) Leading Players

3.3.3 Key Strategic Move: (Product Launches and Product Expansions : 2018, Jun - 2020, Oct) Leading Players

Chapter 4. Global Virtual Clinical Trials Market by Study Type

4.1 Global Interventional Market by Region

4.2 Global Observational Market by Region

4.3 Global Expanded Access Market by Region

Chapter 5. Global Virtual Clinical Trials Market by Indication

5.1 Global Oncology Market by Region

5.2 Global Cardiovascular Market by Region

5.3 Global Immunology Market by Region

5.4 Global Gastrointestinal Market by Region

5.5 Global Respiratory Market by Region

5.6 Global Endocrinology Market by Region

5.7 Global Ophthalmology Market by Region

5.8 Global Other Indications Market by Region

Chapter 6. Global Virtual Clinical Trials Market by Region

6.1 North America Virtual Clinical Trials Market

6.2 Europe Virtual Clinical Trials Market

6.3 Asia Pacific Virtual Clinical Trials Market

6.4 LAMEA Virtual Clinical Trials Market

Chapter 7. Company Profiles

For more information about this report visit https://www.researchandmarkets.com/r/kjc8s7

View source version on businesswire.com: https://www.businesswire.com/news/home/20210416005306/en/

Contacts

ResearchAndMarkets.com
Laura Wood, Senior Press Manager
press@researchandmarkets.com
For E.S.T Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900